The HPV vaccine: framing the arguments FOR and AGAINST mandatory vaccination of all middle school girls
- PMID: 18489462
- DOI: 10.1111/j.1746-1561.2008.00306.x
The HPV vaccine: framing the arguments FOR and AGAINST mandatory vaccination of all middle school girls
Abstract
Background: Human papillomavirus (HPV), the virus responsible for cervical cancer, is the most common viral sexually transmitted infection in the United States. A vaccine was approved in 2006 that is effective in preventing the types of HPV responsible for 70% of cervical cancers and 90% of genital warts. Proposals for routine and mandatory HPV vaccination of girls have become sources of controversy for parents of school-aged youth, legislators, members of the medical community, and the public at large.
Methods: The purpose of this article was to articulate the arguments used by advocates who either oppose or endorse routine, mandatory administration of the vaccine to school-aged girls, thereby assisting school health personnel in being effective participants in framing the relevant issues.
Results: Controversy is grounded in moral, religious, political, economic, and sociocultural arguments including whether concerns that the vaccine increases sexual risk taking, sends mixed messages about abstaining from sexual intercourse, usurps parental authority, and increases the potential for development of new health disparities are offset by the value of administering a cost-effective, age-appropriate public health measure targeting a life-threatening problem.
Conclusions: Careful consideration of the medical evidence and public health implications is critical but understanding the context of the debate is no less important to the task of responding to public concerns. School health personnel have a role in the discussion about HPV immunization. Being able to articulate the arguments presented herein can help authorities' responsiveness to parents and community groups as the dialogue about this particular health issue evolves further.
Similar articles
-
Lessons from the failure of human papillomavirus vaccine state requirements.Clin Pharmacol Ther. 2007 Dec;82(6):760-3. doi: 10.1038/sj.clpt.6100397. Epub 2007 Oct 31. Clin Pharmacol Ther. 2007. PMID: 17971822
-
Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups.J Low Genit Tract Dis. 2009 Apr;13(2):85-93. doi: 10.1097/LGT.0b013e3181865f44. J Low Genit Tract Dis. 2009. PMID: 19387128
-
The HPV vaccine mandate controversy.J Pediatr Adolesc Gynecol. 2007 Dec;20(6):325-31. doi: 10.1016/j.jpag.2007.03.101. J Pediatr Adolesc Gynecol. 2007. PMID: 18082853 Review.
-
Parental acceptance of a mandatory human papillomavirus (HPV) vaccination program.J Am Board Fam Med. 2010 Mar-Apr;23(2):220-9. doi: 10.3122/jabfm.2010.02.090091. J Am Board Fam Med. 2010. PMID: 20207933
-
The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.Pediatr Nurs. 2008 Sep-Oct;34(5):429-31. Pediatr Nurs. 2008. PMID: 19051848 Review.
Cited by
-
State statutes and regulations related to human papillomavirus vaccination.Hum Vaccin Immunother. 2019;15(7-8):1519-1526. doi: 10.1080/21645515.2019.1627817. Epub 2019 Jul 2. Hum Vaccin Immunother. 2019. PMID: 31241406 Free PMC article.
-
Factors influencing adolescent girls' decision in initiation for human papillomavirus vaccination: a cross-sectional study in Hong Kong.BMC Public Health. 2014 Sep 8;14:925. doi: 10.1186/1471-2458-14-925. BMC Public Health. 2014. PMID: 25195604 Free PMC article.
-
Perceived need of a parental decision aid for the HPV vaccine: content and format preferences.Health Promot Pract. 2012 Mar;13(2):214-21. doi: 10.1177/1524839910388622. Epub 2011 Mar 28. Health Promot Pract. 2012. PMID: 21444922 Free PMC article.
-
HPV and Cervical Cancer: Molecular and Immunological Aspects, Epidemiology and Effect of Vaccination in Latin American Women.Viruses. 2024 Feb 21;16(3):327. doi: 10.3390/v16030327. Viruses. 2024. PMID: 38543693 Free PMC article. Review.
-
Is it ethical for immunisations against human papillomavirus to be mandatory in young people aged 12-13 years old?Future Healthc J. 2024 Oct 25;11(4):100204. doi: 10.1016/j.fhj.2024.100204. eCollection 2024 Dec. Future Healthc J. 2024. PMID: 39620051 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical